Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion‐weighted MRI at 3.0 Tesla
暂无分享,去创建一个
[1] Naoko Mori,et al. Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters , 2013, European Radiology.
[2] T. Yoshiura,et al. Correlations between apparent diffusion coefficient values and prognostic factors of breast cancer. , 2013, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[3] R. Ponzone,et al. Correlations between diffusion-weighted imaging and breast cancer biomarkers , 2012, European Radiology.
[4] Katarzyna J Macura,et al. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. , 2010, Radiology.
[5] A. Razek,et al. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors , 2010, NMR in biomedicine.
[6] T. Helbich,et al. Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? , 2009, Radiology.
[7] B. Kang,et al. Diffusion‐weighted imaging of breast cancer: Correlation of the apparent diffusion coefficient value with prognostic factors , 2009, Journal of magnetic resonance imaging : JMRI.
[8] Yoshito Tsushima,et al. Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5‐T , 2009, Journal of magnetic resonance imaging : JMRI.
[9] Mariko Goto,et al. Microperfusion‐induced elevation of ADC is suppressed after contrast in breast carcinoma , 2009, Journal of magnetic resonance imaging : JMRI.
[10] Hiroshi Honda,et al. Apparent diffusion coefficients of breast tumors: clinical application. , 2008, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[11] Steven Sourbron,et al. Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings--preliminary results. , 2008, Radiology.
[12] S. Partridge. Future Applications and Innovations of Clinical Breast Magnetic Resonance Imaging , 2008, Topics in magnetic resonance imaging : TMRI.
[13] Katsuhiro Nasu,et al. Advances in breast MRI: diffusion-weighted imaging of the breast , 2008, Breast cancer.
[14] Yutaka Imai,et al. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer , 2008, Radiation Medicine.
[15] W. B. Veldhuis,et al. Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps , 2008, European Radiology.
[16] Hiromu Nishitani,et al. Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer , 2008, Radiation Medicine.
[17] Bong Joo Kang,et al. The Role of Diffusion-Weighted Imaging and the Apparent Diffusion Coefficient (ADC) Values for Breast Tumors , 2007, Korean journal of radiology.
[18] Evelyn Wenkel,et al. Diffusion weighted imaging in breast MRI: comparison of two different pulse sequences. , 2007, Academic radiology.
[19] T. Mochizuki,et al. Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammography , 2007, Radiation Medicine.
[20] D. Collins,et al. Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.
[21] Y. Sagara,et al. Expression of estrogen receptor alpha and progesterone receptor in normal human breast epithelium. , 2007, In vivo.
[22] A. Cilotti,et al. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion , 2007, European Radiology.
[23] Thomas E Yankeelov,et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. , 2007, Magnetic resonance imaging.
[24] Masahiko Watanabe,et al. Diffusion-Weighted Imaging of Malignant Breast Tumors: The Usefulness of Apparent Diffusion Coefficient (ADC) Value and ADC Map for the Detection of Malignant Breast Tumors and Evaluation of Cancer Extension , 2005, Journal of computer assisted tomography.
[25] Masanori Ozaki,et al. ADC mapping of benign and malignant breast tumors. , 2005, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[26] C. Boesch,et al. Diffusion‐weighted imaging of the parotid gland: Influence of the choice of b‐values on the apparent diffusion coefficient value , 2004, Journal of magnetic resonance imaging : JMRI.
[27] I. Bauerfeind,et al. Association between HER-2/neu and Vascular Endothelial Growth Factor Expression Predicts Clinical Outcome in Primary Breast Cancer Patients , 2004, Clinical Cancer Research.
[28] R. Bammer. Basic principles of diffusion-weighted imaging. , 2003, European journal of radiology.
[29] Gottfried Konecny,et al. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. , 2003, Journal of the National Cancer Institute.
[30] Naobumi Yashiro,et al. Diffusion-Weighted Half-Fourier Single-Shot Turbo Spin Echo Imaging in Breast Tumors: Differentiation of Invasive Ductal Carcinoma from Fibroadenoma , 2002, Journal of computer assisted tomography.
[31] Ning-Yu An,et al. Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[32] Usha Sinha,et al. In vivo diffusion‐weighted MRI of the breast: Potential for lesion characterization , 2002, Journal of magnetic resonance imaging : JMRI.
[33] R. Kumar,et al. The role of HER2 in angiogenesis. , 2001, Seminars in oncology.
[34] S G Hilsenbeck,et al. Significance of axillary lymph node metastasis in primary breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] I. Ellis,et al. Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.
[36] N. Goldstein,et al. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. , 1997, The American journal of pathology.
[37] L D Buadu,et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. , 1996, Radiology.
[38] D M Shames,et al. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. , 1996, Radiology.
[39] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.
[40] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[41] H. Dvorak,et al. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. , 1988, The American journal of pathology.
[42] D. Le Bihan,et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.